ROR2, VANGL2, and DVLs were demonstrated to be involved in the WNT pathway [54, 55], serving as pivotal regulators of proliferation, metastasis, and development of colon cancer, thyroid cancer, and melanoma [56–59]. Here, VANGL2 is linked to colonic neoplasm.